Clinical trials query results
From Health Canada
- Medical condition:
- TREATMENT RESISTANT DEPRESSION
- Study population:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN/ RISPERIDONE/ SDM-8 18F
- Protocol title:
- IMAGING THE EFFECTS OF SEROTONIN 2A RECEPTOR MODULATION ON SYNAPTIC DENSITY IN TREATMENT-RESISTANT DEPRESSION (SYNVEST)
- Sponsor name:
- CENTRE FOR ADDICTION AND MENTAL HEALTH
- Date of no objection letter:
- 2023-09-13
- Control number:
- 278284
- Trial status:
- ONGOING
- Date study started:
- 2025-03-24